Dulaglutide drug aliquots can be used for in vitro or in vivo experiments. Several other reference drugs are also available.
The drug aliquots are generated by aliquoting (dividing and repackaging) the EU-licensed biosimilar drug.
Find and order your therapeutic molecules through smart filters
Up to 10 batches of original drugs for examining batch-to-batch variations
Up to 80% less compared to the original pharmaceutical price
Shipment within days worldwide according to GDP-standards
Up to 80% less compared to the original pharmaceutical price
| Drug name | Trulicity® |
| INN | Dulaglutide |
| API type | Glycoprotein |
| Pharmacotherapeutic group | Drugs used in diabetes, blood glucose lowering drugs, excl. insulins |
| ATC code | A10BJ05 |
| Target of antibody | |
| General function | Dulaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as a monotherapy or in conjunction with other medicinal products for the treatment of diabetes. |
| Short description | |
| Pharmacodynamic properties (Mechanism of action; Source EMA document) | Dulaglutide is a long-acting glucagon-like peptide 1 (GLP-1) receptor agonist. The molecule consists of 2 identical disulfide-linked chains, each containing a modified human GLP-1 analogue sequence covalently linked to a modified human immunoglobulin G4 (IgG4) heavy chain fragment (Fc) by a small peptide linker. |
| Pharmacodynamic properties (Pharmacodynamic effects; Source EMA document) | Dulaglutide improves glycaemic control through the sustained effects of lowering fasting, pre-meal and postprandial glucose concentrations in patients with type 2 diabetes starting after the first dulaglutide administration and is sustained throughout the once weekly dosing interval. |
| Original license holder | Eli Lilly Nederland B.V. Papendorpseweg 83 3528 BJ Utrecht The Netherlands |
| Marketing authorisation numbers | EU/1/14/956/004 EU/1/14/956/005 EU/1/14/956/009 EU/1/14/956/010 |
| Marketing authorisation holder | Eli Lilly Nederland B.V. Papendorpseweg 83 3528 BJ Utrecht The Netherlands |
| Name of the manufacturer of the biological active substance | Eli Lilly Kinsale Limited Dunderrow Kinsale Co. Cork Ireland |
| Name and address of the manufacturer(s) responsible for batch release | Eli Lilly Italia S.p.A. Via Gramsci 731/733 50019, Sesto Fiorentino Firenze (FI) Italy Lilly France 2, rue du Colonel Lilly 67640 Fegersheim France |
| Max shelf life | 2 years |
| Storage conditions | 2°C – 8°C |
| List of excipients | Sodium citrate Citric acid Mannitol Polysorbate 80 Water for injections |
Evidentic offers multiple batches of original drug aliquots in low binding Eppendorf tubes for research use only. We provide licence-free drug aliquots with long, short or even “negative shelf life” by storing the products at recommended temperatures (either 2-8°C or -80°C) and ensuring fully functional molecules for research purposes.
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany
